AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MEDICLINIC INTERNATIONAL PLC

Report Publication Announcement Jun 15, 2016

4946_rns_2016-06-15_def0df75-a799-4820-8633-db700dcb031f.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0619B

Mediclinic International PLC

15 June 2016

Mediclinic International plc

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

15 June 2016

Mediclinic International Middle East Site Visit

Mediclinic International plc ("Mediclinic" or the "Company"), a leading international private healthcare group, is today hosting a two day site visit of its Middle East platform. The event will be hosted by David Hadley, Chief Executive Officer of Mediclinic Middle East, and will include visits to several of the platform's hospitals and clinics in Abu Dhabi and Dubai, in addition to presentations on the Company's Middle East operations.

No new trading or financial information will be disclosed. Copies of the presentations will be made available on the Company's website: www.mediclinic.com 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International

Gert Hattingh, Executive Group Services

+27 (0)21 809 6500

Bell Pottinger

Liz Morley/Aarti Iyer/Lucy Stewart

+44 (0)203 772 2468

Notes:

Mediclinic is the world's third largest listed acute hospital operator (outside of the United States), with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective acute care specialised hospital services. The group operates 73 hospitals and 45 clinics.

Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE-listed private healthcare group based in the UK.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCAKNDQABKDDAD

Talk to a Data Expert

Have a question? We'll get back to you promptly.